Form HA-4631 is the Social Security Administration’s “Claimant’s Medications” worksheet that disability claimants use to disclose every prescription and over-the-counter drug they take, along with the prescribing source, dosage, and side effects, before an Administrative Law Judge (ALJ) hearing. You fill it out by listing each medication on its own line, identifying the doctor or clinic that prescribed it, the condition it treats, the dosage and frequency, and any side effects you experience, then signing and dating the form before submitting it to the Office of Hearings Operations at least five business days before your hearing.
The form exists because 20 CFR § 404.1529 and 20 CFR § 416.929 require the ALJ to weigh the type, dosage, effectiveness, and side effects of medication when judging the intensity and persistence of your symptoms. If you skip the form or leave it incomplete, the ALJ may discount your pain testimony, and the five-day evidence rule under 20 CFR § 404.935 can block late submissions, which often leads to a denial that could have been a win.
Roughly two-thirds of Social Security disability claims are denied at the initial level, and only about 54% of hearing-level decisions result in a fully or partially favorable outcome, so every piece of evidence — including HA-4631 — matters.
Here is what you will learn in this guide:
- 💊 How to list every medication, dosage, and side effect the right way on Form HA-4631
- 📅 When the form is due under the five-day rule and how to avoid late-evidence rejection
- ⚖️ Why the ALJ uses your medication list under the SSR 16-3p symptom evaluation framework
- 📝 Three named real-world examples that show line-by-line completion
- 🚫 Seven mistakes that quietly sink claims and how to dodge each one
What Form HA-4631 Actually Is
Form HA-4631, titled Claimant’s Medications, is a one-page Social Security Administration worksheet issued by the Office of Hearings Operations (OHO), formerly known as ODAR. The form is sent to claimants in the hearing-notice packet after a request for hearing is filed under 20 CFR § 404.929. The plain-English purpose is to give the ALJ a clean, current snapshot of every drug you take so the judge does not have to dig through hundreds of pages of treatment notes to find it.
The consequence of ignoring the form is real. The ALJ can find that the lack of a documented medication regimen undercuts your alleged severity, which is a credibility hit under SSR 16-3p. A common misconception is that medical records alone cover this ground, but treatment notes are often outdated, inconsistent, or silent on side effects, so the form fills that gap.
For example, Maria, a fibromyalgia claimant in Phoenix, submitted HA-4631 listing gabapentin, duloxetine, and cyclobenzaprine with documented drowsiness and dizziness. The judge cited her side effect profile when finding she could not sustain concentration for unskilled work, and she won. Without HA-4631, that nuance would have been buried.
Where the Form Lives in the Appeals Process
HA-4631 belongs to the hearing stage, which is the third level of the Social Security disability appeals ladder. The first level is the initial application processed by Disability Determination Services (DDS), the second is reconsideration, and the third is the ALJ hearing. The form appears only after you receive a Notice of Hearing, usually 75 days before the hearing date as required by HALLEX I-2-3-20.
The consequence of misunderstanding the timing is missing the five-day rule, which can render the form inadmissible. A common misconception is that you can hand the form to the judge at the hearing — you generally cannot, absent good cause.
Who Issues and Who Receives the Form
The form is issued by the Office of Hearings Operations and is mailed to the claimant and any appointed representative. The recipient is the assigned ALJ, but the form is filed through the hearing office or uploaded by your representative through Electronic Records Express (ERE). The plain-English point is that the judge reads it cover to cover before the hearing.
A common misconception is that the SSA field office handles HA-4631 — it does not. The hearing office controls the file once a hearing is requested under 20 CFR § 404.933.
Why the ALJ Cares About Your Medications
Medications are one of the seven factors the ALJ must weigh when evaluating symptom intensity under SSR 16-3p. The other factors include daily activities, location and duration of pain, precipitating factors, treatment other than medication, self-help measures, and other factors concerning functional limitations. Each medication tells a story about severity, response to treatment, and ability to work.
The consequence of skipping medications is a credibility problem. If you allege disabling pain but list no pain medications, the judge will likely conclude under 20 CFR § 404.1529(c)(3) that your symptoms are not as severe as alleged. A common misconception is that taking only over-the-counter drugs hurts your case — it does not, as long as you explain why under SSR 18-3p, which addresses failure to follow prescribed treatment.
For example, James, a back pain claimant in Atlanta, listed only Tylenol and ibuprofen because his insurance lapsed. He attached a note explaining the gap, and the ALJ found the explanation credible under SSR 18-3p, awarding benefits.
Side Effects Are the Hidden Gold
Side effects are the single most underused field on HA-4631. Drowsiness, dizziness, nausea, blurred vision, and cognitive fogging — sometimes called opioid brain fog — can independently support a finding that you cannot sustain a 40-hour workweek. The Medical-Vocational Guidelines treat sustained concentration as essential for unskilled work.
The consequence of leaving side effects blank is that the ALJ assumes you have none. A common misconception is that side effects must appear in your chart to count — they do not, because 20 CFR § 404.1529(c)(3)(iv) requires the ALJ to consider your own statements about side effects.
How Vocational Experts Use the Form
The Vocational Expert (VE) at your hearing answers hypothetical questions about jobs in the national economy. If your representative includes a side effect like moderate drowsiness three hours per day in the hypothetical, the VE will usually testify that no competitive jobs exist. That outcome flows directly from the medication list on HA-4631.
The consequence of a thin medication list is a thin hypothetical, which means the VE finds plenty of jobs and you lose. A common misconception is that the VE reads the whole file — VEs typically rely on what the ALJ and your attorney spotlight at the hearing.
A Line-by-Line Walkthrough of HA-4631
The form is short, but every blank carries weight. The current version of Form HA-4631 is downloadable from SSA.gov and is also pre-printed in the hearing notice envelope. Below is a field-by-field guide.
Header Block: Name, SSN, and Date
The top of the form asks for your full legal name, your Social Security number, and the date you complete the form. Use the name that appears on your application and the SSN that matches your claim file under 20 CFR § 422.103. A mismatched name or SSN can cause the form to be misfiled, which is a real risk in busy hearing offices.
The consequence of a typo is a delayed file association, which can push your case past the five-day rule. A common misconception is that nicknames are fine — they are not, because the file is indexed by legal name. For example, Robert should not write “Bob” even if everyone calls him Bob.
Column 1: Name of Medication
List the brand name and the generic name when you know both, separated by a slash, like Cymbalta/duloxetine. Use the spelling on the prescription bottle to avoid confusion. The FDA Orange Book is a free tool to confirm spellings.
The consequence of guessing or misspelling is that the ALJ may not match the drug to your treatment notes, which can weaken the credibility of your list under SSR 16-3p. A common misconception is that over-the-counter drugs do not belong here — they do, because 20 CFR § 404.1529(c)(3)(iv) covers any medication taken for symptom relief.
Column 2: Prescribed By (or Self if OTC)
Identify the prescribing provider’s full name and specialty, like Dr. Lin Patel, Pain Management. If the medication is over-the-counter, write Self and note who recommended it. This column ties each drug to a treating source, which matters under the revised treating-source rules in 20 CFR § 404.1520c.
The consequence of leaving this blank is that the ALJ cannot trace the drug to a record, which weakens its evidentiary weight. A common misconception is that you must list the clinic instead of the doctor — list the doctor, then add the clinic in parentheses if helpful.
Column 3: Condition Treated
State the underlying diagnosis in plain English, like neuropathic pain in lower back or major depressive disorder. Match the condition to the impairments listed in your Disability Report (Form SSA-3368) so the ALJ can connect the dots quickly.
The consequence of vague entries like pain or anxiety is that the judge may not link the drug to a medically determinable impairment under 20 CFR § 404.1521. A common misconception is that diagnoses must be quoted from a chart — they do not, but they must be reasonably consistent with the record.
Column 4: Dosage and Frequency
Write the strength, the unit, and the frequency exactly as prescribed, like 60 mg, one tablet by mouth twice daily. Use the abbreviations on the prescription bottle, but spell out anything unusual. The DailyMed database is a free reference for dosing.
The consequence of vague dosing like as needed without a maximum is ambiguity that hurts credibility. A common misconception is that PRN (as needed) is enough — add the cap, like up to four times daily, so the judge sees the ceiling.
Column 5: Side Effects
This is the most important column. List every side effect you actually experience, even mild ones, like drowsiness, dry mouth, occasional dizziness on standing. Quantify when possible, like drowsiness lasting two to three hours after each dose.
The consequence of writing None when you actually have side effects is a permanent waiver of that argument at the hearing. A common misconception is that you must prove side effects with a lab test — you do not, because 20 CFR § 404.1529(c)(3)(iv) credits your own reports.
Signature and Date Block
Sign the form in ink and write the date. If a representative completes the form on your behalf, the representative should attach a cover letter and use Form SSA-1696 to confirm the appointment.
The consequence of an unsigned form is that the hearing office may treat it as a draft and never associate it with the file. A common misconception is that an electronic signature in ERE requires a special certificate — it does not, because SSA accepts wet, electronic, and stamped signatures from appointed representatives.
Three Real-World Examples
Below are three named scenarios that show how to fill the form for very different impairment profiles. Each example reflects common impairments seen at the hearing level, where the SSA Annual Statistical Report shows musculoskeletal, mental, and neurological conditions dominate the docket.
Example 1: Maria, Fibromyalgia and Depression
Maria is a 47-year-old former medical biller in Phoenix. Her fibromyalgia diagnosis is supported under SSR 12-2p, and her depression is documented in Listing 12.04. She lists gabapentin 600 mg three times daily, duloxetine 60 mg daily, cyclobenzaprine 10 mg at bedtime, and ibuprofen 400 mg as needed up to three times daily. Her side effect column shows drowsiness four hours after gabapentin doses, dry mouth, and morning grogginess from cyclobenzaprine.
The consequence of her detailed side effect column is that her attorney built a hypothetical for the VE that included off-task time exceeding 15%, which the Dictionary of Occupational Titles does not tolerate for unskilled work. The VE testified no jobs existed, and the ALJ awarded benefits.
Example 2: James, Lumbar Degenerative Disc Disease
James is a 54-year-old former warehouse worker in Atlanta. His MRI shows multilevel disc herniation, supporting Listing 1.15. He lists oxycodone 5 mg every six hours, meloxicam 15 mg daily, methocarbamol 750 mg three times daily, and Tylenol Extra Strength 500 mg as needed. His side effect column shows constipation, sedation requiring a daily nap, and difficulty concentrating for more than 20 minutes.
The consequence of disclosing the daily nap is that the VE conceded no jobs accommodate unscheduled napping, which is consistent with Program Operations Manual System (POMS) DI 25001.001 defining sustained work activity. James won at step five.
Example 3: Aisha, Major Depressive Disorder and PTSD
Aisha is a 36-year-old former teacher in Chicago whose mental impairments fall under Listings 12.04 and 12.15. She lists sertraline 200 mg daily, prazosin 5 mg at bedtime, bupropion XL 300 mg daily, and lorazepam 0.5 mg as needed up to twice daily. Her side effect column reads cognitive fogging, weight gain, sexual side effects, and emotional blunting.
The consequence of listing emotional blunting is that her therapist’s notes about reduced affect aligned with the medication profile, which the ALJ cited when finding marked limitations in interacting with others under the paragraph B criteria. She received a fully favorable decision.
Three Common Scenario Tables
Each table below pairs a typical claimant decision with the likely judge-level outcome. These scenarios reflect patterns reported in the SSA Office of the Inspector General audits of hearing decisions.
Scenario Table A: Listing All Medications vs. Listing Only Prescriptions
| Claimant Choice | ALJ Outcome |
|---|---|
| Lists prescriptions plus OTC drugs with dosages and side effects | Judge credits full symptom picture under SSR 16-3p, often leading to favorable RFC |
| Lists only prescriptions, omits OTC pain relievers and sleep aids | Judge may find conservative treatment, leading to a less restrictive RFC and possible denial |
Scenario Table B: Detailed Side Effects vs. Blank Side Effects
| Claimant Choice | ALJ Outcome |
|---|---|
| Quantifies drowsiness, fogging, and nausea with timeframes | VE hypothetical includes off-task time, often eliminating all jobs |
| Writes none or leaves blank | Judge presumes no functional impact from medication, weakening credibility |
Scenario Table C: Submitting on Time vs. Submitting Late
| Claimant Choice | ALJ Outcome |
|---|---|
| Submits HA-4631 at least five business days before hearing | Form is admitted under 20 CFR § 404.935, evidence considered in full |
| Submits at the hearing without good cause | ALJ may exclude the form, leaving the medication record incomplete |
Mistakes to Avoid
Below are the most damaging errors people make on HA-4631. Each mistake is followed by the negative outcome that tends to follow.
- Listing only prescription medications and ignoring over-the-counter drugs, which makes the treatment look conservative and weakens credibility under SSR 16-3p.
- Writing None in the side effects column when side effects exist, which permanently waives a powerful argument before the Vocational Expert.
- Using vague dosing like as needed without a maximum, which signals casual use and lets the ALJ discount severity.
- Listing medications you no longer take without marking them discontinued, which confuses the record and may suggest exaggeration under 20 CFR § 404.1529.
- Submitting the form fewer than five business days before the hearing without showing good cause, which can trigger exclusion under 20 CFR § 404.935(b).
- Forgetting to sign and date the form, which can cause the hearing office to treat it as a draft and never index it to your file.
- Mismatching diagnoses with the impairments listed on Form SSA-3368, which breaks the chain between symptom and impairment under 20 CFR § 404.1521.
- Using shorthand the judge cannot decode, like qid prn, without a plain-English translation, which slows the judge and invites adverse inferences.
- Failing to update the form after a medication change, which leaves a stale record that contradicts your live testimony.
Filing, Timing, and the Five-Day Rule
The form is due in the hearing file at least five business days before your hearing. The five-day rule under 20 CFR § 404.935 and the parallel SSI rule at 20 CFR § 416.1435 give the ALJ discretion to exclude late evidence absent one of the listed good-cause exceptions.
The consequence of late filing is exclusion, which can flatten your case. A common misconception is that the ALJ must accept evidence up to the day of the hearing — that has not been true since the 2017 amendments to the regulations.
For example, Robert, a claimant in Dallas, faxed his HA-4631 the night before his hearing. The ALJ refused to admit it because Robert could not show good cause. Robert lost on credibility grounds the form would have fixed.
Good Cause Exceptions
The good cause exceptions under 20 CFR § 404.935(b) include actions by SSA that misled the claimant, physical, mental, educational, or linguistic limitations, and unavoidable circumstances beyond the claimant’s control. Each exception requires a written explanation in the record.
The consequence of asserting good cause without proof is a denied request, leaving the form excluded. A common misconception is that representatives are exempt from the rule — they are not, and HALLEX I-2-6-58 confirms representatives must comply.
Submitting Through Electronic Records Express
Appointed representatives upload HA-4631 through Electronic Records Express, which provides a confirmation receipt. Pro se claimants can fax the form to the hearing office or mail it certified.
The consequence of mailing without tracking is no proof of delivery, which can be fatal under the five-day rule. A common misconception is that ERE is only for attorneys — non-attorney representatives appointed under Form SSA-1696 also have access.
How HA-4631 Interacts With Other Hearing Forms
HA-4631 does not stand alone. It works with Form HA-4632 (Claimant’s Recent Medical Treatment), Form HA-4633 (Claimant’s Work Background), and the older Form SSA-3441 (Disability Report – Appeal). Together, these forms give the ALJ a complete picture of treatment, work history, and symptoms.
The consequence of filing HA-4631 alone is an unbalanced record. A common misconception is that submitting one of these forms covers the others — they each cover different ground.
For example, Aisha’s representative filed HA-4631, HA-4632, and HA-4633 together, which let the ALJ cross-reference treatment, medications, and past relevant work in one sitting. The judge wrote a faster decision because the file was organized.
Coordination With Treating Source Statements
A treating source statement, sometimes called a medical source statement, should match the medications listed on HA-4631. Inconsistencies hurt both documents under the persuasiveness factors in 20 CFR § 404.1520c.
The consequence of mismatch is that the ALJ may find the treating source unpersuasive. A common misconception is that the doctor’s note will explain mismatches automatically — it will not unless prompted.
Do’s and Don’ts
- Do list every drug, including OTC and supplements, because 20 CFR § 404.1529 considers all symptom-related treatment.
- Do quantify side effects with timeframes and intensity, because vague entries lose credibility.
- Do match diagnoses to your SSA-3368, because consistency strengthens the file.
- Do update the form before the hearing if a prescription changes, because stale data invites adverse inferences.
-
Do submit through Electronic Records Express or certified mail, because proof of delivery protects you under the five-day rule.
-
Don’t leave side effects blank, because the judge will presume none.
- Don’t use undefined shorthand, because clarity wins cases.
- Don’t list discontinued medications without marking them, because confusion equals doubt.
- Don’t miss the five-day deadline, because exclusion is harsh and routine.
- Don’t sign for someone else, because that violates the certification language and can trigger fraud review under 20 CFR § 404.459.
Pros and Cons of Filing HA-4631 Carefully
- Pro: A detailed form supports a stronger RFC argument under SSR 96-8p, because medications and side effects feed directly into functional limits.
- Pro: The form gives your representative ammunition for VE hypotheticals, because off-task time and unscheduled breaks are job-killers.
- Pro: The form fills documentation gaps treatment notes often miss, because doctors rarely chart subjective side effects.
- Pro: A clean form speeds the judge’s decision, because organized files draft faster.
-
Pro: Filing on time preserves all your evidentiary arguments, because the five-day rule cuts both ways.
-
Con: A poorly completed form can affirmatively hurt your case, because admissions are binding.
- Con: The form is a snapshot, so it can become stale quickly, because medication regimens change often.
- Con: Listing strong opioids may invite questions about addiction risk, because some judges consider SSR 13-2p on drug and alcohol issues.
- Con: Side effect claims invite cross-examination, because the VE may be asked about objective verification.
- Con: Errors are hard to fix mid-hearing, because the five-day rule limits late corrections.
Federal vs. State Nuances
Form HA-4631 is a federal SSA form, and the Social Security Act at 42 U.S.C. § 405 governs its use uniformly nationwide. There is no state version, and no state law modifies it. However, regional differences exist in how hearing offices handle late submissions and electronic filings.
The consequence of assuming uniformity is missed local quirks. A common misconception is that state Medicaid records substitute for the form — they do not, because the form is the claimant’s own attestation.
Regional Hearing Office Differences
Some hearing offices, particularly in the SSA Region IV (Atlanta) and Region IX (San Francisco) jurisdictions, enforce the five-day rule strictly. Others, such as smaller offices in the Mountain West, sometimes accept late forms when good cause is plausible.
The consequence of relying on regional leniency is unpredictable outcomes. A common misconception is that the rules vary by judge — they vary by office culture, but the regulation is the same.
State DDS Records Are Not a Substitute
State Disability Determination Services agencies handle the initial and reconsideration stages, and their records do flow to the hearing office. But the records are often months old by the time you reach the ALJ, which is why HA-4631 exists.
The consequence of skipping HA-4631 because DDS already has my list is an outdated record. A common misconception is that the ALJ will pull current pharmacy data — the ALJ will not, because the burden is on the claimant under 20 CFR § 404.1512.
Recap of Relevant Rulings and Precedents
The Social Security Administration relies heavily on Social Security Rulings and selected federal court decisions to guide ALJs. The most relevant authorities for HA-4631 are below.
SSR 16-3p replaces the older credibility framework with a symptom-evaluation framework that treats medication type, dosage, effectiveness, and side effects as core factors. The consequence is that medication evidence is now central, not peripheral. A common misconception is that credibility analysis still applies — it does not.
SSR 96-8p governs the residual functional capacity assessment and requires the ALJ to discuss the side effects of medication. The consequence is that an ALJ who ignores side effects risks reversal. A common misconception is that RFC is purely physical — it includes mental and side-effect-driven limits.
SSR 18-3p addresses failure to follow prescribed treatment. The consequence is that explaining gaps in medication, like the OTC-only situation James faced, can preserve a claim. A common misconception is that any gap kills a case — it does not, when documented.
Lucia v. SEC, 138 S. Ct. 2044 (2018) reshaped ALJ appointments. The consequence for HA-4631 is collateral, but appointment challenges sometimes ride alongside evidentiary issues at the Appeals Council.
FAQs
Is Form HA-4631 mandatory?
No. The form is technically optional, but skipping it almost always hurts your case because the ALJ uses it to evaluate symptoms under SSR 16-3p.
Can I list over-the-counter medications on HA-4631?
Yes. OTC drugs count as treatment under 20 CFR § 404.1529, and listing them shows you treat your symptoms even without insurance.
Do I have to list every side effect, even mild ones?
Yes. Mild side effects can add up to off-task time that eliminates jobs at the Vocational Expert stage of the hearing.
Will the ALJ exclude my form if I file it late?
Yes. Under the five-day rule at 20 CFR § 404.935, late forms can be excluded absent good cause shown in writing.
Can my representative sign HA-4631 for me?
No. The claimant must sign, but a representative appointed via Form SSA-1696 can prepare the form and submit it electronically.
Does HA-4631 replace HA-4632?
No. HA-4631 covers medications, while HA-4632 covers recent medical treatment, and the ALJ expects both at the hearing stage.
Can I update HA-4631 after I submit it?
Yes. Submit a revised form through Electronic Records Express before the five-day cutoff to keep the record current.
Will marijuana, including medical marijuana, count as a medication?
Yes. List it with the recommending provider’s name, but be aware that SSR 13-2p on drug issues may apply to evaluation.
Do I need to attach receipts or pharmacy records?
No. The form is a self-attestation, and 20 CFR § 404.1529(c)(3)(iv) credits your own statements about medication and side effects.
Can I refuse to fill out HA-4631?
Yes. You have the right to refuse, but the ALJ may draw negative inferences and your symptom credibility may suffer under SSR 16-3p.
Does the form apply to SSI claims as well as SSDI?
Yes. The parallel SSI five-day rule at 20 CFR § 416.1435 applies, and HA-4631 is used in both Title II and Title XVI hearings.
What if my dosage changes the day before the hearing?
Yes, you should notify the ALJ in writing immediately, because HALLEX I-2-6-58 allows late evidence when changes happen after the five-day window.
Related reading
- How to Fill Out Form HA-4632 (w/Examples) + FAQs
- How to Fill Out Form HA-4633 (w/Examples) + FAQs
- How to Fill Out Form HA-539 (w/Examples) + FAQs
- How to Fill Out Form HA-85 (w/Examples) + FAQs
- How to Fill Out Form HA-86 (w/Examples) + FAQs
- How to Fill Out Form HA-L90 (w/Examples) + FAQs
- How to Fill Out Form SSA-8001-BK (w/Examples) + FAQs